These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22150551)

  • 1. Validation of MMPI-2-RF validity scales in criterion group neuropsychological samples.
    Schroeder RW; Baade LE; Peck CP; VonDran EJ; Brockman CJ; Webster BK; Heinrichs RJ
    Clin Neuropsychol; 2012; 26(1):129-46. PubMed ID: 22150551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scores on the MMPI-2-RF scales as a function of increasing levels of failure on cognitive symptom validity tests in a military sample.
    Jones A; Ingram MV; Ben-Porath YS
    Clin Neuropsychol; 2012; 26(5):790-815. PubMed ID: 22709365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the MMPI-2 restructured form (MMPI-2-RF) validity scales in civil forensic settings: findings from simulation and known group samples.
    Wygant DB; Ben-Porath YS; Arbisi PA; Berry DT; Freeman DB; Heilbronner RL
    Arch Clin Neuropsychol; 2009 Nov; 24(7):671-80. PubMed ID: 19797242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in MMPI-2 FBS and RBS scores in brain injury, probable malingering, and conversion disorder groups: a preliminary study.
    Peck CP; Schroeder RW; Heinrichs RJ; Vondran EJ; Brockman CJ; Webster BK; Baade LE
    Clin Neuropsychol; 2013; 27(4):693-707. PubMed ID: 23510271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Let's not get hysterical: comparing the MMPI-2 validity, clinical, and RC scales in TBI litigants tested for effort.
    Thomas ML; Youngjohn JR
    Clin Neuropsychol; 2009 Aug; 23(6):1067-84. PubMed ID: 19343593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and specificity of MMPI-2 validity scales and indicators to malingered neurocognitive dysfunction in traumatic brain injury.
    Greve KW; Bianchini KJ; Love JM; Brennan A; Heinly MT
    Clin Neuropsychol; 2006 Sep; 20(3):491-512. PubMed ID: 16895861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent validation of the MMPI-2-RF Somatic/Cognitive and Validity scales in TBI Litigants tested for effort.
    Youngjohn JR; Wershba R; Stevenson M; Sturgeon J; Thomas ML
    Clin Neuropsychol; 2011 Apr; 25(3):463-76. PubMed ID: 21391149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between Symptom Validity Test failure and scores on the MMPI-2-RF validity and substantive scales.
    Gervais RO; Wygant DB; Sellbom M; Ben-Porath YS
    J Pers Assess; 2011; 93(5):508-17. PubMed ID: 21859291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the MMPI-2 restructured form (MMPI-2-RF) and malingered neurocognitive dysfunction among non-head injury disability claimants.
    Tarescavage AM; Wygant DB; Gervais RO; Ben-Porath YS
    Clin Neuropsychol; 2013; 27(2):313-35. PubMed ID: 23181937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating constructs represented by symptom validity tests in forensic neuropsychological assessment of traumatic brain injury.
    Frederick RI; Bowden SC
    J Head Trauma Rehabil; 2009; 24(2):105-22. PubMed ID: 19333066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity indicators within the Wisconsin Card Sorting Test: application of new and previously researched multivariate procedures in multiple traumatic brain injury samples.
    King JH; Sweet JJ; Sherer M; Curtiss G; Vanderploeg RD
    Clin Neuropsychol; 2002 Dec; 16(4):506-23. PubMed ID: 12822059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregation across multiple indicators improves the detection of malingering: relationship to likelihood ratios.
    Larrabee GJ
    Clin Neuropsychol; 2008 Jul; 22(4):666-79. PubMed ID: 17886147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malingering detection with the Wisconsin Card Sorting Test in mild traumatic brain injury.
    Greve KW; Heinly MT; Bianchini KJ; Love JM
    Clin Neuropsychol; 2009 Feb; 23(2):343-62. PubMed ID: 18609328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance validity and neuropsychological outcomes in litigants and disability claimants.
    Davis JJ; McHugh TS; Axelrod BN; Hanks RA
    Clin Neuropsychol; 2012; 26(5):850-65. PubMed ID: 22630329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of the MMPI-2-RF in detecting non-credible somatic complaints.
    Sellbom M; Wygant D; Bagby M
    Psychiatry Res; 2012 May; 197(3):295-301. PubMed ID: 22405634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the MMPI-2-RF for Detecting Over-reported Symptoms in a Civil Forensic and Disability Setting.
    Nguyen CT; Green D; Barr WB
    Clin Neuropsychol; 2015; 29(2):255-71. PubMed ID: 25905684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting malingering in traumatic brain injury and chronic pain with an abbreviated version of the Meyers Index for the MMPI-2.
    Aguerrevere LE; Greve KW; Bianchini KJ; Meyers JE
    Arch Clin Neuropsychol; 2008; 23(7-8):831-8. PubMed ID: 18715751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A known-groups evaluation of the response bias scale in a neuropsychological setting.
    Sullivan KA; Elliott CD; Lange RT; Anderson DS
    Appl Neuropsychol Adult; 2013; 20(1):20-32. PubMed ID: 23373681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncredible cognitive performance in the context of severe brain injury.
    Boone KB; Lu P
    Clin Neuropsychol; 2003 May; 17(2):244-54. PubMed ID: 13680432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification accuracy of the Portland Digit Recognition Test in traumatic brain injury: results of a known-groups analysis.
    Greve KW; Bianchini KJ
    Clin Neuropsychol; 2006 Dec; 20(4):816-30. PubMed ID: 16980264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.